Enver Akbaş

Enver Akbaş

Auto-generated profile, based on publicly available information

Enver Akbaş

Department of Gastroenterology, Faculty of Medicine, Istanbul Medipol University, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2019 in Turkish Journal of Gastroenterology
Verified
Journal Article
Open access
EAEnver Akbaş
Enver Akbaş
RAReskan Altun
Reskan Altun
Cite this article as: Akbaş E, Altun R. A non-obstructive gastric antral web case detected after upper gastrointestinal system bleeding. Turk J Gastroenterol 2019; 30: 15-6.

7 February 2021 in Medical Science and Discovery
Verified
Journal Article
Open access
EAEnver Akbaş
Enver Akbaş
GÜGÖZDE ÜLFER
GÖZDE ÜLFER
Objective: In this study, we compared the serum zonulin levels in patients diagnosed for the first time with active ulcerative colitis with those in healthy cases and attempted to determine whether serum zonulin levels were different in the active ulcerative colitis. Material and Methods: A total of 53 naive patients admitted to our hospital between 2019 and 2020 and diagnosed with active ulcerative colitis by colonoscopy were included as a group of cases and 37 patients with no acute or chronic diseases whose colonoscopy was normal as the control group. Results: The study was conducted on 90 cases, 65.5% male and 34.5% female. The patients with ulcerative colitis were compared with the control group in terms of serum zonulin levels. Average serum zonulin levels of the patients with ulcerative colitis (16.73 ± 5.49 ng/ml) were not significantly different than those in the control group 17.48 ± 8.31 ng/ml). Serum zonulin levels of the patients were also compared according to location and severity of disease and did not differ statistically significantly between the groups in terms of the Montreal Classification. When serum zonulin levels were grouped according to the Truelove and Witts criteria, there was no statistically significant difference between the patient groups themselves and the control group. Conclusion: Serum zonulin levels were not greater in the patients with naive active ulcerative colitis compared to the healthy controls. Several previous studies have shown that serum zonulin levels are elevated in patients with ulcerative colitis, but more studies are needed on this subject.

15 April 2019 in Endoskopi Gastrointestinal
Verified
Journal Article
Closed access
EAEnver Akbaş
Enver Akbaş
Giriş ve Amaç: Araştırmamızda hastanemizde çeşitli endikasyonlar ile üst gastrointestinal sistem endoskopisi yapılan hastalarda özofagus fungal enfeksiyonlarının sıklığını, başvuru semptomlarının dağılımını, buna zemin hazırlayan durumları değerlendirmeye çalıştık. Gereç ve Yöntem: 2015-2019 yılları arasında hastanemize başvuran ve üst gastrointestinal sistem endoskopisi yapılan 2862 hastadan endoskopik olarak özofagusta fungal enfeksiyon tespit edilen ve mikrobiyolojik olarak bu tanısı doğrulanan 33 hasta değerlendirmeye alındı. Bulgular: Toplam 2862 hastanın 33 (%1,2) tanesinde özofagusta fungal enfeksiyon tespit edildi. Eşlik eden hastalık olarak en sık %71 ile reflü özofajit zemininde fungal enfeksiyon gelişmişti. Hiçbir hastada insan bağışıklık yetmezliği virüsü pozitifliği tespit edilemedi. Hastaların %27,3’ünde immünsupresyona neden olan bir patoloji ya da ilaç kullanımı mevcut iken %72,7’sinde böyle bir neden tespit edilemedi. Hastaların başvuru şikayeti olguların %21.2’sinde disfaji, %6.1’inde hıçkırık, %21.2’sinde reflü semptomları, %6.1’inde ses kısıklığı, %6.1’inde kilo kaybı, %15.2’sinde bulantı-kusma iken %42.4 ile hastaların çoğunluğunda mide ağrısı gibi klasik bir dispeptik yakınma şeklindeydi. Sonuç: Dünyada Kandida özofajitinin en sık nedeni insan bağışıklık yetmezliği virüsü enfeksiyonu, maligniteler ve immünsüpresyon yaratan durumlardır. Bizim hastalarımızda Kandida enfeksiyonuna daha çok reflü özofajit eşlik etmekte iken sadece %15 hastada enfeksiyon immünsüpresyon yaratan bir durumda gelişmişti. Bulgularımız insan bağışıklık yetmezliği virüsü negatif hasta profilindeki dünya literatür verileri ile uyumu bulundu.

26 April 2018 in Endoskopi Gastrointestinal
Verified
Journal Article
Closed access
PDF file
EAEnver Akbaş
Enver Akbaş
SÖSerkan Öcal
Serkan Öcal
AYAbdullah Emre Yildirim
Abdullah Emre Yildirim
RAReskan Altun
Reskan Altun
MKMurat Korkmaz
Murat Korkmaz
HSHaldun Selçuk
Haldun Selçuk
Anastomoz darlıkları kolorektal cerrahinin bilinen bir komplikasyonu olmasına rağmen benign hastalıklarda komplet kolonik anastomoz obstrüksiyonu nadirdir. Benign darlıklar low-anterior rezeksiyon sonrası yapılan kolorektal anastomozda nispeten sık görülen bir komplikasyondur ve kolorektal anastomozların %5-22’sinde gelişebilir. Günümüzde benign anastomoz darlıklarının tedavisinde ilk seçenek endoskopik girişimlerdir. Çeşitli endoskopik teknikler tarif edilmesine rağmen optimal yaklaşım için kontrollü prospektif çalışma verileri eksiktir. Bu çalışmada ileri derecede anastomoz darlığı gelişmiş ve endoskopik balon dilatasyon uygulanan bir hastanın sunulması amaçlandı. Hastaya bir haftalık rektal mesalazin tedavisinden sonra bir kez ayaktan balon dilatasyonu uygulandı ve darlık giderildi. Rektal mesalazin uygulamasının darlık bölgesindeki inflamutuvar sürece olumlu etkisi oldu ve balon dilatasyon sayısını azalttı. Kolorektal darlıkların tedavisinde endoskopik balon dilatasyon 1985’ten beri kullanılmaktadır. Minimal invaziv bir yöntemdir, başarı oranı yüksektir, güvenle direkt görüş altında yapılabilir, tekrarlanabilir ve hastanede yatış gerektirmez.

29 April 2022 in Medical Science and Discovery
Verified
Journal Article
Open access
PDF file
EAEnver Akbaş
Enver Akbaş
MAMustafa Salih Akın
Mustafa Salih Akın
Objective: Inflammatory bowel diseases (IBDs) are polygenic disorders. Patients with IBD, especially ulcerative colitis (UC), are more vulnerable to infections because of medications. Key COVID-19-related factors/risks have not been well-researched in IBD patients. In this study, we compared IBD patients with control patients who presented to our clinic with COVID-19 infection suspicion regarding COVID-19 PCR test positivity, COVID-19 pneumonia, hospitalization, and need for treatment at the intensive care unit (ICU). Material and Methods: Thiscohort study included 480 IBD patients as cases and 9,269 age- and gender-matched control patients who came to our hospital for complaints/checkups and were tested for COVID-19 PCR. Results: Covid-19 positivity was higher in IBD patients than in controls. COVID-19 pneumonia rates were higher in IBD compared to the pneumonia rate of Turkey — mainly due to the high prevalence of COVID-19 pneumonia in UC as none of the Crohn’s disease (CD) patients experienced COVID-19 pneumonia. Hospitalization was significantly higher in UC than in CD and higher in IBD than in controls. Hospitalization at ICU was significantly higher in UC than in the controls. There were no IBD patients who died because of COVID-19 infection. Conclusion: IBD patients have a significantly higher rate of COVID-19 PCR positivity, COVID-19 pneumonia, hospitalization, and the need for ICU than the controls; however, mortality is comparable.

20 June 2025 in Medicine
Verified
Journal Article
Open access
EAEnver Akbas
Enver Akbas
GÜGÖZDE ÜLFER
GÖZDE ÜLFER
Distinguishing between benign and malignant masses during endoscopic examination of colon masses is critical; however, predictive parameters other than lesion appearance are lacking. This study aimed to compare the zonulin levels in colorectal cancer tissues with those in normal colon tissues to ascertain their diagnostic value. Our study included 108 patients in the study group whose colonoscopy revealed a mass in the colon and whose biopsy revealed adenocarcinoma, and 60 healthy individuals in the control group with normal colonoscopy findings. Three samples were collected: 1 cancerous tissue, 1 healthy tissue (approximately 10–15 cm from the cancerous tissue in the study group), and 1 healthy colon tissue in the control group. These samples were stored at –80°C and their zonulin levels were compared to determine their correlation with clinical variables. The sample size was calculated with a 95% confidence interval and 80% power. As a result of this calculation, 108 patients and 60 control group participants were identified. Control group selection criteria were determined as follows: Healthy individuals matched to the study group in terms of age and gender. The median zonulin levels in the study group were 60.98 ng/mL in cancerous tissues, 27.98 ng/mL in noncancerous tissues, and 15.80 ng/mL in the control group. Zonulin levels in cancerous tissues were significantly higher than those in healthy tissues (60.98 vs 27.98, respectively, P < .001) and control tissues (60.98 vs 15.80, respectively, P < .001). Significantly higher zonulin levels were noted in both healthy and tumor tissues of female patients than in those of male patients (30.30 vs 22.45, P < .001 and 63.17 vs 49.36, P = .009, respectively). The median zonulin level in colorectal adenocarcinoma tissues was significantly higher than that in the healthy colon tissues of the control group and normal colon tissues of patients with cancer. If corroborated by future studies, zonulin levels may serve as a potential predictive marker with diagnostic value.